Latin American medicinal cannabis producer Blueberries Medical Corp. BBM BBRRF has closed a C$1 million ($740,000) non-brokered private placement offering, completed in the form of unsecured convertible debentures.
Among the investors was entrepreneur Facundo Garreton, a social impact leader and former member of congress in Argentina.
Garreton joined the cannabis industry earlier this year as both investor and strategic advisor for YVY Life Sciences.
“I am increasingly committed to this exciting industry,” Garreton told Benzinga. “Cannabis has significant therapeutic potential to solve various health problems.”
See also: Argentina To Allow Cannabis Sales In Pharmacies And Home Cultivation
Regarding his active involvement in Blueberries, Garreton said: “They have an excellent team, an ideal place for the production of cannabis, and unique technology for extraction.”
This will allow for collaborations and synergies with other initiatives the Yale Global Fellow is involved in.
Garreton disclosed Blueberries and YVY will work together on various initiatives, both on the research front and the “cannabis productive value chain, to help many people with ailments and with natural and organic solutions. ”
Courtesy image
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!